Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?

医学 癌症 精密医学 内科学 肿瘤科 病理
作者
Timothée Olivier,Eugenio Fernández,Sana Intidhar Labidi‐Galy,Pierre‐Yves Dietrich,Verónica Rodríguez-Bravo,Giulia Baciarello,Karim Fizazi,Anna Patrikidou
出处
期刊:Cancer Treatment Reviews [Elsevier BV]
卷期号:97: 102204-102204 被引量:51
标识
DOI:10.1016/j.ctrv.2021.102204
摘要

The concept of Cancer of Unknown Primary (CUP) has evolved with the advent of medical oncology. CUP can be difficult to diagnose and represents 2 to 5% of new cancers, therefore not exceptionally rare. Within CUPs can be identified a subset of favourable prognosis tumours, however the vast majority of CUP patients belongs to a poor prognosis group.CUP features significant oncological challenges, such as unravelling biological and transversal issues, and most importantly, improving patient’s outcomes. In that regard, CUP patients’ outcomes regrettably showed minimal improvement for decades and CUP remains a cancer group of very poor prognosis.The biology of CUP has two main hypotheses. One is that CUP is a subgroup of a given primary cancer, where the primary is present but cannot be seen due to its small size. The other, the “true” CUP hypothesis, states that CUP share features that make them a specific entity, whatever their tissue of origin. A true biological signature has not yet been described, but chromosomal instability is a hallmark of poor prognosis CUP group.Precision oncology, despite achieving identifying the putative origin of the CUP, so far failed to globally improve outcomes of patients. Targeting molecular pathways based on molecular analysis in CUP management is under investigation. Immunotherapy has not shown ground-breaking results, to date. Accrual is also a crucial issue in CUP trials.Herein we review CUP history, biological features and remaining questions in CUP biology, the two main approaches of molecular oncology in CUP management, in order to draw perspectives in the enormous challenge of improving CUP patient outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
aaa完成签到,获得积分10
刚刚
1秒前
漂亮糖豆完成签到,获得积分10
1秒前
西辞发布了新的文献求助10
2秒前
3秒前
SUZHEN发布了新的文献求助10
3秒前
乐乐完成签到,获得积分10
3秒前
黑米粥发布了新的文献求助200
4秒前
louis完成签到,获得积分10
4秒前
奔跑的小眼完成签到,获得积分10
4秒前
6秒前
爆米花的应助被伯克利芙蓉王采纳,获得10
6秒前
Tsing_Summer发布了新的文献求助10
6秒前
爆米花的应助被66666采纳,获得30
6秒前
7秒前
fzkls完成签到,获得积分10
7秒前
jackhlj完成签到,获得积分10
7秒前
hins完成签到,获得积分10
8秒前
8秒前
9秒前
10秒前
10秒前
sptyzl完成签到 ,获得积分0
11秒前
11秒前
11秒前
搜集达人的应助被认真白猫采纳,获得10
12秒前
小番茄发布了新的文献求助20
14秒前
jinrui发布了新的文献求助10
14秒前
淡淡的铭发布了新的文献求助10
14秒前
Tsing_Summer完成签到,获得积分10
14秒前
14秒前
jx完成签到,获得积分10
15秒前
木兮发布了新的文献求助10
15秒前
拼搏凝冬发布了新的文献求助10
15秒前
15秒前
16秒前
chenjie完成签到,获得积分10
16秒前
Marcus完成签到,获得积分10
16秒前
lucky发布了新的文献求助10
17秒前
烨采发布了新的文献求助10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187592
求助须知:如何正确求助?哪些是违规求助? 9575705
关于积分的说明 21842471
捐赠科研通 7785407
什么是DOI,文献DOI怎么找? 3435057
关于科研通互助平台的介绍 2559461
邀请新用户注册赠送积分活动 2481952